Skip to main content
Department of Pediatrics

Pediatrics News

Currently, pediatric patients with acute lymphoblastic leukemia receive similar treatments, and clinicians are unable to predict the outcomes. However, a groundbreaking new technology called GradientScreen can predict how children will respond to any given combination of cancer treatments and dosages before the intervention begins, saving invaluable time. 

According to the Blue Ridge Institute for Medical Research, an independent, non-profit organization, Emory University received more than $511 million in NIH funding in 2025.

New biomedical technology developed at Emory and Georgia Tech detects and monitors for anemia in a completely non-invasive way with just a photo of a fingernail using an AI-powered algorithm.

Events

Loading Events...